3rd Annual Atlanta Precision Oncology Symposium

 

3rd Annual Atlanta Precision Oncology Symposium
I

CNS Metastases in HER2+ MBC: PFS Data on the Addition of Tucatinib to Capecitabine and Trastuzumab

By 3rd Annual Atlanta Precision Oncology Symposium FEATURING Ingrid Mayer
By 3rd Annual Atlanta Precision Oncology Symposium FEATURING Ingrid Mayer
605 views
February 9, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

18:11
Incyte

Appropriate Management of RPED (Retinal Pigment Epithelial Detachmen…

Feat. M. Khasawneh

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss
Videos
12:36

Genotype-Directed Therapy for Advanced NSCLC: Overview of Targeted T…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

542 views
26:48

Targeted Therapies for Advanced Urothelial Cancer: Erdafitinib for P…

3rd Annual Atlanta Precision Oncology Symposium

D. Petrylak

148 views
13:52

Targeted Therapy for Advanced NSCLC: Efficacy Analysis of RET, KRAS,…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

38 views
25:48

2021 Expert Discussion on GU Cancers: Should We Use Olaparib Before …

3rd Annual Atlanta Precision Oncology Symposium

E. Antonarakis, D. Petrylak, T. Zhang

239 views
26:48

Treatment of DNA Repair-Deficient Advanced Prostate Cancer

3rd Annual Atlanta Precision Oncology Symposium

E. Antonarakis

244 views
26:42

2021 Expert Discussion on Advanced NSCLC: Is Osimertinib a Good Sequ…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon, N. Hanna, H. Borghaei, J. Kirkpatrick

393 views
23:13

Early Detection of Lung Cancer: Molecular Enrichment Strategy

3rd Annual Atlanta Precision Oncology Symposium

J. Kirkpatrick

101 views
18:36

Selecting Systemic First-Line Treatment in Stage IV NSCLC Without Dr…

3rd Annual Atlanta Precision Oncology Symposium

N. Hanna

327 views
20:20

2021 Expert Discussion on BC: How to Preoperatively Manage TNBC? How…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer, J. Litton, R. O’Regan

38 views
32:45

2021 Updates on Systemic Therapy for TNBC: Why Should We Choose Neoa…

3rd Annual Atlanta Precision Oncology Symposium

R. O’Regan

50 views
06:49

IO for mTNBC: Overview of the Efficacy Data

3rd Annual Atlanta Precision Oncology Symposium

J. Litton

352 views
13:30

ADCs & Targeted Therapies for Advanced TNBC: Can Sacituzumab Govitec…

3rd Annual Atlanta Precision Oncology Symposium

J. Litton

97 views
09:52

EGFR+ Advanced NSCLC: Should 1L Therapy Include an EGFR Inhibitor Re…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon

99 views
15:01

EGFR+ Advanced NSCLC: Efficacy Data of TKIs in Combination vs. Alone…

3rd Annual Atlanta Precision Oncology Symposium

E. Garon

141 views
05:55

Sequence Algorithm for HER2+ Breast Cancer: Does Neratinib + Cape Ha…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

31 views
05:03

CNS Metastases in HER2+ MBC: PFS Data on the Addition of Tucatinib t…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

605 views
17:47

HER2+ MBC Sequencing Algorithm: Surveying the Data for Antibody-Drug…

3rd Annual Atlanta Precision Oncology Symposium

I. Mayer

37 views
14:04
3rd Annual Atlanta Precision Oncology Symposium

[PRIVATE] Targeted Therapies for mRCC: Surveying Efficacy Data for I…

Feat. T. Zhang
17:05
3rd Annual Atlanta Precision Oncology Symposium

[PRIVATE] Targeted Therapies for mRCC: Assessing IMDC Risk Criteria …

Feat. T. Zhang
08:45

Targeting Genetic Mutations in mNSCLC: Clinical Data Overview of RET…

3rd Annual Atlanta Precision Oncology Symposium

H. Dilks

284 views